- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinical study of penetration of flomoxef into serum and pancreatic juice.
-
- Fujii Hideki
- First Department of Surgery, Yamanashi Medical University
-
- Kobayashi Masashi
- First Department of Surgery, Yamanashi Medical University
-
- Matsumoto Yoshiro
- First Department of Surgery, Yamanashi Medical University
Bibliographic Information
- Other Title
-
- Flomoxefのすい液移行に関する臨床的検討
Search this article
Description
To evaluate the organ penetration of flomoxef (FMOX), we investigated its concentration in serum and pancreatic juice of 14 patients after intravenous injection of a 2 g FMOX. The results obtained were as follows:<BR>1. The peak concentration of FMOX in serum was 134.3±32.1 μg/ml and occured 30 minutes after administration.<BR>2. The peak concentration of FMOX in pancreatic juice was 4.69±4.12 μg/ml and occured 30 minutes after administration.<BR>3. High concentrations of FMOX in pancreatic juice were observed even at 2 hours after administration.<BR>4. Bacteria isorated from drained pancreatic juice were mainly Escherichia coli and Klebsiella pneumoniae for which the MIC of FMOX was less than 0.1 μg/ml. Thus FMOX was affective against these bacteria in pancreatic juice.<BR>5. Rates of penetration of FMOX into pancreata affected by fibrosis were lower than into pan-creata without fibrosis.
Journal
-
- Japanese Journal of Chemotherapy
-
Japanese Journal of Chemotherapy 45 (9), 741-745, 1997
Japanese Society of Chemotherapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282681262522496
-
- NII Article ID
- 130004297833
-
- ISSN
- 18845886
- 13407007
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed